BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9790472)

  • 1. Indomethacin and pancreatic enzymes synergistically damage intestine of rats.
    Kimura RE; Arango V; Lloyd-Still J
    Dig Dis Sci; 1998 Oct; 43(10):2322-32. PubMed ID: 9790472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.
    FitzSimmons SC; Burkhart GA; Borowitz D; Grand RJ; Hammerstrom T; Durie PR; Lloyd-Still JD; Lowenfels AB
    N Engl J Med; 1997 May; 336(18):1283-9. PubMed ID: 9113931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of intestinal permeability on pancreatic enzyme-induced enteropathy in the rat.
    Lloyd-Still JD; Uhing MR; Arango V; Fusaro A; Kimura RE
    J Pediatr Gastroenterol Nutr; 1998 May; 26(5):489-95. PubMed ID: 9586757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of high-dose ibuprofen and pancreatic enzymes on the intestine of the rat.
    Kimura RE; Dy SA; Uhing MR; Beno DW; Jiyamapa VA; Lloyd-Still JD
    J Pediatr Gastroenterol Nutr; 1999 Aug; 29(2):178-83. PubMed ID: 10435655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy.
    Stevens JC; Maguiness KM; Hollingsworth J; Heilman DK; Chong SK
    J Pediatr Gastroenterol Nutr; 1998 Jan; 26(1):80-4. PubMed ID: 9443125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic enzymes and fibrosing colonopathy.
    Bakowski M
    Lancet; 1999 Jul; 354(9174):249; author reply 251. PubMed ID: 10421321
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrosing colonopathy in cystic fibrosis: results of a case-control study.
    Kapadia C
    Gastroenterology; 1996 Jul; 111(1):260-1. PubMed ID: 8698212
    [No Abstract]   [Full Text] [Related]  

  • 8. Ursodeoxycholic acid ameliorates ibuprofen-induced enteropathy in the rat.
    Lloyd-Still JD; Beno DW; Uhing MR; Jiyamapa-Serna VA; Kimura RE
    J Pediatr Gastroenterol Nutr; 2001 Mar; 32(3):270-3. PubMed ID: 11345174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrosing colonopathy in an adult owing to over use of pancreatic enzyme supplements.
    Bansi DS; Price A; Russell C; Sarner M
    Gut; 2000 Feb; 46(2):283-5. PubMed ID: 10644326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrosing colonopathy in children with cystic fibrosis.
    Reichard KW; Vinocur CD; Franco M; Crisci KL; Flick JA; Billmire DF; Schidlow DV; Weintraub WH
    J Pediatr Surg; 1997 Feb; 32(2):237-41; discussion 241-2. PubMed ID: 9044129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathology of fibrosing colonopathy of cystic fibrosis: a study of 12 cases and review of the literature.
    Pawel BR; de Chadarévian JP; Franco ME
    Hum Pathol; 1997 Apr; 28(4):395-9. PubMed ID: 9104936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic enzymes and fibrosing colonopathy.
    Lloyd-Still JD; Beno DW; Uhing MR; Kimura RE
    Lancet; 1999 Jul; 354(9174):251. PubMed ID: 10421325
    [No Abstract]   [Full Text] [Related]  

  • 13. Colonic strictures in children with cystic fibrosis on low-strength pancreatic enzymes.
    van Velzen D
    Lancet; 1995 Aug; 346(8973):499-500. PubMed ID: 7543642
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibrosing colonopathy in an adult cystic fibrosis patient after discontinuing pancreatic enzyme therapy.
    Mack EH; Brett AS; Brown D
    South Med J; 2004 Sep; 97(9):901-4. PubMed ID: 15455984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An animal model of longitudinal ulcers in the small intestine induced by intracolonically administered indomethacin in rats.
    Matsumoto T; Iida M; Nakamura S; Hizawa K; Kuroki F; Fujishima M
    Gastroenterol Jpn; 1993 Feb; 28(1):10-7. PubMed ID: 8440416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative and experimental pathology of fibrosing colonopathy.
    van Velzen D; Ball LM; Dezfulian AR; Southgate A; Howard CV
    Postgrad Med J; 1996 Mar; 72 Suppl 2():S39-48; discussion S49-51. PubMed ID: 8869182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is fibrosing colonopathy an immune mediated disease?
    Lee J; Ip W; Durie P
    Arch Dis Child; 1997 Jul; 77(1):66-70. PubMed ID: 9279159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indomethacin, dexamethasone, and intestinal damage in infant rats.
    Patel MR; DeMarco VG; Clare-Salzler M; Li YY; Neu J
    J Pediatr Gastroenterol Nutr; 2002 Aug; 35(2):154-61. PubMed ID: 12187290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concern about records of fibrosing colonopathy study.
    Dodge JA
    Lancet; 2001 May; 357(9267):1526-7. PubMed ID: 11383534
    [No Abstract]   [Full Text] [Related]  

  • 20. Colonic strictures in patients with cystic fibrosis: results of a survey of 114 cystic fibrosis care centers in the United States.
    Freiman JP; FitzSimmons SC
    J Pediatr Gastroenterol Nutr; 1996 Feb; 22(2):153-6. PubMed ID: 8642487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.